Methodologic Issues in the Measurement of Cytokines to Elucidate the Biological Basis for Cancer Symptoms

被引:25
作者
Gilbertson-White, Stephanie [1 ]
Aouizerat, Bradley E. [1 ]
Miaskowski, Christine [1 ]
机构
[1] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
cytokines; molecular markers; symptom clusters; SICKNESS BEHAVIOR; MULTIPLEX IMMUNOASSAY; INTERFERON-ALPHA; ASSOCIATION; SPECIFICITY; ACTIVATION; INTERLEUKIN-2; DEREGULATION; SENSITIVITY; VALIDATION;
D O I
10.1177/1099800410379497
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Multiple concurrent symptoms are highly prevalent in patients with cancer. However, little is known about the relationships among these symptoms and their underlying mechanisms. A number of cytokines that are involved in the development of sickness behavior are hypothesized to be a mechanism for symptom clusters. Measurement of these cytokines would provide valuable information that could be used to elucidate mechanisms underlying the development of symptom clusters and the identification of potential targets for intervention studies. In this article, the authors explore several issues that warrant careful consideration when designing a research study involving the use of a cytokine as a biomarker in symptom cluster research. These issues include which molecules to measure, which specimens to collect, the timing of specimen collection and processing, and which technologies to use to measure the biomarker and the sensitivity and specificity of the assay system. The article begins with a brief discussion of cytokines and sickness behavior and the role of the cytokines in cancer-related symptoms.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 42 条
[1]  
Ader R, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, pXV, DOI 10.1016/B978-012088576-3/50001-0
[2]   Preliminary Evidence of a Genetic Association Between Tumor Necrosis Factor Alpha and the Severity of Sleep Disturbance and Morning Fatigue [J].
Aouizerat, Bradley E. ;
Dodd, Marylin ;
Lee, Kathryn ;
West, Claudia ;
Paul, Steven M. ;
Cooper, Bruce A. ;
Wara, William ;
Swift, Patrick ;
Dunn, Laura B. ;
Miaskowski, Christine .
BIOLOGICAL RESEARCH FOR NURSING, 2009, 11 (01) :27-41
[3]   Measurement of cytokines in clinical samples using immunoassays: Problems and pitfalls [J].
Banks, RE .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2000, 37 (02) :131-182
[4]  
Barsevick Andrea M, 2007, Semin Oncol Nurs, V23, P89, DOI 10.1016/j.soncn.2007.01.009
[5]  
BRIDGE TP, 1986, CLIN NEUROPHARMACOL, V9, P473
[6]   Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-α treatments in cancer patients [J].
Capuron, L ;
Ravaud, A ;
Dantzer, R .
PSYCHOSOMATIC MEDICINE, 2001, 63 (03) :376-386
[7]   Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy [J].
Capuron, L ;
Ravaud, A ;
Gualde, N ;
Bosmans, E ;
Dantzer, R ;
Maes, M ;
Neveu, PJ .
PSYCHONEUROENDOCRINOLOGY, 2001, 26 (08) :797-808
[8]   Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? [J].
Capuron, Lucile ;
Fornwalt, Fiona B. ;
Knight, Bettina T. ;
Harvey, Philip D. ;
Ninan, Philip T. ;
Miller, Andrew H. .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 119 (1-3) :181-185
[9]  
Cashion Ann K, 2004, Biol Res Nurs, V5, P159, DOI 10.1177/1099800403257458
[10]   Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms [J].
Cleeland, CS ;
Bennett, GJ ;
Dantzer, R ;
Dougherty, PM ;
Dunn, AJ ;
Meyers, CA ;
Miller, AH ;
Payne, R ;
Reuben, JM ;
Wang, XS ;
Lee, BN .
CANCER, 2003, 97 (11) :2919-2925